PLENAXIS Drug Patent Profile
✉ Email this page to a colleague
When do Plenaxis patents expire, and what generic alternatives are available?
Plenaxis is a drug marketed by Speciality European and is included in one NDA.
The generic ingredient in PLENAXIS is abarelix. Additional details are available on the abarelix profile page.
Summary for PLENAXIS
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 45 |
Clinical Trials: | 3 |
Patent Applications: | 5,098 |
DailyMed Link: | PLENAXIS at DailyMed |
Recent Clinical Trials for PLENAXIS
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
PRAECIS Pharmaceuticals Inc. | Phase 4 |
PRAECIS Pharmaceuticals Inc. | Phase 2 |
Speciality European Pharma Limited | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for PLENAXIS
US Patents and Regulatory Information for PLENAXIS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Speciality European | PLENAXIS | abarelix | INJECTABLE;INTRAMUSCULAR | 021320-001 | Nov 25, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PLENAXIS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Speciality European | PLENAXIS | abarelix | INJECTABLE;INTRAMUSCULAR | 021320-001 | Nov 25, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
Speciality European | PLENAXIS | abarelix | INJECTABLE;INTRAMUSCULAR | 021320-001 | Nov 25, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
Speciality European | PLENAXIS | abarelix | INJECTABLE;INTRAMUSCULAR | 021320-001 | Nov 25, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
Speciality European | PLENAXIS | abarelix | INJECTABLE;INTRAMUSCULAR | 021320-001 | Nov 25, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
Speciality European | PLENAXIS | abarelix | INJECTABLE;INTRAMUSCULAR | 021320-001 | Nov 25, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PLENAXIS
See the table below for patents covering PLENAXIS around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 1398037 | Formulations pharmaceutiques pour administration de médicaments à libération prolongée (Pharmaceutical formulations comprising a water-insoluble complex for sustained drug delivery) | ⤷ Try a Trial |
Australia | 6168096 | ⤷ Try a Trial | |
Hong Kong | 1064918 | ⤷ Try a Trial | |
World Intellectual Property Organization (WIPO) | 2007022254 | ⤷ Try a Trial | |
World Intellectual Property Organization (WIPO) | 9640757 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for PLENAXIS
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0794961 | C300484 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: ABARELIX, EVENTUEEL IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; NAT. REGISTRATION NO/DATE: RVG 104389 20101220; FIRST REGISTRATION: 57890.00.00 20050922 |
0794961 | SPC/GB11/006 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: ABARELIX, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: DE - 20050922; UK PL32828/001 20100917 |
0794961 | 91225 | Luxembourg | ⤷ Try a Trial | 91225, EXPIRES: 20200922 |
0794961 | 1190014-9 | Sweden | ⤷ Try a Trial | PRODUCT NAME: ABARELIX |
0794961 | 11C0015 | France | ⤷ Try a Trial | PRODUCT NAME: ABARELIX, EVENTUELLEMENT SOUS FORME DE SEL PHARMACEUTIQUEMENT ACCEPTABLE; REGISTRATION NO/DATE IN FRANCE: 69026150 DU 20101126; REGISTRATION NO/DATE AT EEC: 57890.00.00 DU 20050922 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |